Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines

HF Wu, K Chen and JC Shih

Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles 90033.

Nine cysteines are found in the deduced amino acid sequences of both human liver monoamine oxidase (MAO)-A and MAO-B. The role of these cysteine residues in MAO-A and -B catalytic activity was studied by site-directed mutagenesis, whereby each cysteine residue was converted to serine. The wild-type and mutant cDNAs were then transiently transfected into COS cells and assayed for MAO-A and -B catalytic activity using 5-[3H]hydroxytryptamine and [14C]phenylethylamine, respectively, as substrates. Catalytic activities were retained in seven MAO-A cysteine to serine mutants (mutations at residues 165, 210, 266, 306, 321, 323, and 398) and in six MAO-B cysteine to serine mutants (mutations at residues 5, 172, 192, 297, 312, and 389). Kinetic parameters (Km) of these mutants were also similar to those of the wild- type enzymes, indicating that these cysteines are not necessary for enzymatic activity. Substitution of MAO-A Cys-374 and -406 and MAO-B Cys-156, -365, and -397 with serine resulted in complete loss of MAO-A and -B catalytic activity. The loss of catalytic activity was not due to unsuccessful transfection of the mutants, as indicated by either Northern blot or Western blot analysis. The loss of catalytic activity in the MAO-A Ser-406 and MAO-B Ser-397 mutants may be due to the prevention of covalent binding of the enzyme to the cofactor FAD, which is necessary for catalytic activity. The loss of catalytic activity of MAO-A Ser-374 and MAO-B Ser-156 and -365 suggests that these cysteines are important for catalytic activity, but whether they are involved in forming the active site or are important for the appropriate conformation of MAO-A and -B remains to be studied.

Volume 43, Issue 6, pp. 888-893, 06/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z. Zhang, K. Chen, J. C. Shih, and C. T. Teng Estrogen-Related Receptors-Stimulated Monoamine Oxidase B Promoter Activity Is Down-Regulated by Estrogen Receptors Mol. Endocrinol., July 1, 2006; 20(7): 1547 - 1561. [Abstract] [Full Text] [PDF]

				L. De Colibus, M. Li, C. Binda, A. Lustig, D. E. Edmondson, and A. Mattevi Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B PNAS, September 6, 2005; 102(36): 12684 - 12689. [Abstract] [Full Text] [PDF]

				K. Chen, D. P. Holschneider, W. Wu, I. Rebrin, and J. C. Shih A Spontaneous Point Mutation Produces Monoamine Oxidase A/B Knock-out Mice with Greatly Elevated Monoamines and Anxiety-like Behavior J. Biol. Chem., September 17, 2004; 279(38): 39645 - 39652. [Abstract] [Full Text] [PDF]

				W. K. Wong, K. Chen, and J. C. Shih Decreased Methylation and Transcription Repressor Sp3 Up-regulated Human Monoamine Oxidase (MAO) B Expression during Caco-2 Differentiation J. Biol. Chem., September 19, 2003; 278(38): 36227 - 36235. [Abstract] [Full Text] [PDF]

				F. Hubalek, J. Pohl, and D. E. Edmondson Structural Comparison of Human Monoamine Oxidases A and B: MASS SPECTROMETRY MONITORING OF CYSTEINE REACTIVITIES J. Biol. Chem., August 1, 2003; 278(31): 28612 - 28618. [Abstract] [Full Text] [PDF]

				R. M. Geha, K. Chen, J. Wouters, F. Ooms, and J. C. Shih Analysis of Conserved Active Site Residues in Monoamine Oxidase A and B and Their Three-dimensional Molecular Modeling J. Biol. Chem., May 3, 2002; 277(19): 17209 - 17216. [Abstract] [Full Text] [PDF]

				J. F. Cryan, A. Dalvi, S.-H. Jin, B. R. Hirsch, I. Lucki, and S. A. Thomas Use of Dopamine-beta -hydroxylase-Deficient Mice to Determine the Role of Norepinephrine in the Mechanism of Action of Antidepressant Drugs J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 651 - 657. [Abstract] [Full Text] [PDF]

				B. P. Zhou, B. Wu, S.-W. Kwan, and C. W. Abell Characterization of a Highly Conserved FAD-binding Site in Human Monoamine Oxidase B J. Biol. Chem., June 12, 1998; 273(24): 14862 - 14868. [Abstract] [Full Text] [PDF]

				S. O. Sablin and R. R. Ramsay Monoamine Oxidase Contains a Redox-active Disulfide J. Biol. Chem., June 5, 1998; 273(23): 14074 - 14076. [Abstract] [Full Text] [PDF]

				B. P. Zhou, D. A. Lewis, S.-W. Kwan, and C. W. Abell Flavinylation of Monoamine Oxidase B J. Biol. Chem., October 6, 1995; 270(40): 23653 - 23660. [Abstract] [Full Text] [PDF]

				O Cases, I Seif, J Grimsby, P Gaspar, K Chen, S Pournin, U Muller, M Aguet, C Babinet, J. Shih, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA Science, June 23, 1995; 268(5218): 1763 - 1766. [Abstract] [PDF]

				R. K. Nandigama and D. E. Edmondson Influence of FAD Structure on Its Binding and Activity with the C406A Mutant of Recombinant Human Liver Monoamine Oxidase A J. Biol. Chem., June 30, 2000; 275(27): 20527 - 20532. [Abstract] [Full Text] [PDF]

				R. M. Geha, I. Rebrin, K. Chen, and J. C. Shih Substrate and Inhibitor Specificities for Human Monoamine Oxidase A and B Are Influenced by a Single Amino Acid J. Biol. Chem., March 23, 2001; 276(13): 9877 - 9882. [Abstract] [Full Text] [PDF]

				I. Rebrin, R. M. Geha, K. Chen, and J. C. Shih Effects of Carboxyl-terminal Truncations on the Activity and Solubility of Human Monoamine Oxidase B J. Biol. Chem., July 27, 2001; 276(31): 29499 - 29506. [Abstract] [Full Text] [PDF]